Herpes Zoster: all 370 studies
Page 2 of 4. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.
- Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in ItalyCompletedNCT01772160Results posted
- Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersCompletedNCT01767467Phase 3Results posted
- Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or OlderCompletedNCT01751165Phase 3Results posted
- Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173ACompletedNCT01610414Phase 3Results posted
- ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)CompletedNCT01556451Phase 4Results posted
- Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3Results posted
- A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)CompletedNCT01527383Phase 2Results posted
- Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)CompletedNCT01527370Phase 3Results posted
- Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination RatesCompletedNCT01519570Not applicableResults posted
- Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3Results posted
- Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)CompletedNCT01505647Phase 3Results posted
- Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue HospitalCompletedNCT01483378Not applicableResults posted
- A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)CompletedNCT01460719Phase 1Results posted
- Immunogenicity and Safety Study of ZOSTAVAX Administered by Intramuscular or Subcutaneous Route to Participants Aged From 50 Years Old (V211-045)CompletedNCT01391546Phase 3Results posted
- A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2)CompletedNCT01385566Phase 1Results posted
- Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and ElderlyCompletedNCT01331161Not applicableResults posted
- Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy SubjectsCompletedNCT01295320Phase 2Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)CompletedNCT01254630Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)CompletedNCT01245751Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)CompletedNCT01229267Phase 3Results posted
- Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CVCompletedNCT01190228Phase 3Results posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and OlderCompletedNCT01165229Phase 3Results posted
- Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected SubjectsCompletedNCT01165203Phase 2Results posted
- Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderCompletedNCT01165177Phase 3Results posted
- A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)CompletedNCT01077804Results posted
- ProQuad Dose Selection Study (V221-011)(COMPLETED)CompletedNCT00986232Phase 2Results posted
- A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3Results posted
- Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3Results posted
- ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3Results posted
- Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3Results posted
- Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of ShinglesCompletedNCT00921934Results posted
- Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173ACompletedNCT00920218Phase 2Results posted
- Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working SeedsCompletedNCT00892775Phase 2Results posted
- A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)CompletedNCT00886613Phase 1Results posted
- Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral TherapyCompletedNCT00851786Phase 2Results posted
- A Study of ProQuad™ in Healthy Children in Korea (V221-023)TerminatedNCT00839917Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 YearsCompletedNCT00802464Phase 2Results posted
- Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM).CompletedNCT00792623Phase 2Results posted
- Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3Results posted
- A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)CompletedNCT00696709Phase 1Results posted
- Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)CompletedNCT00681031Phase 4Results posted
- Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of AgeCompletedNCT00578175Phase 2Results posted
- Study of Two Formulations of GSK Biologicals' Varicella VaccineCompletedNCT00568334Phase 2Results posted
- Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043)CompletedNCT00561080Phase 3Results posted
- Safety Study of ProQuad® rHA in Infants (V221-037)CompletedNCT00560755Phase 3Results posted
- ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)CompletedNCT00550745Phase 4Results posted
- ZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)CompletedNCT00546819Phase 2Results posted
- ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)CompletedNCT00535730Phase 3Results posted
- A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)CompletedNCT00535236Phase 1Results posted
- Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)CompletedNCT00534248Phase 3Results posted
- Month 30 & 42 Extension Studies of CRD-004 Primary StudyCompletedNCT00492648Phase 2Results posted
- Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy ToddlersCompletedNCT00483574Phase 3Results posted
- Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly SubjectsCompletedNCT00434577Phase 2Results posted
- Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)CompletedNCT00432042Phase 3Results posted
- Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3Results posted
- A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersCompletedNCT00384397Phase 3Results posted
- A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)CompletedNCT00322231Phase 3Results posted
- A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)CompletedNCT00231816Phase 3Results posted
- Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3Results posted
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)CompletedNCT00130793Phase 3Results posted
- Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected PatientsCompletedNCT00127608Phase 3Results posted
- Efficacy and Safety of High-Concentration 35 kDa Hyaluronan Gel for Herpes Zoster-Associated PainCompletedNCT07569978Not applicable
- Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and DementiaActive, not recruitingNCT07485283Phase 4
- Postherpetic Neuralgia After Herpes Zoster and Incident Dementia RiskCompletedNCT07399288
- A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and OlderActive, not recruitingNCT07311148Phase 2
- A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)Active, not recruitingNCT07293065Phase 3
- Study on Booster Immunization With Varicella Vaccine at Different IntervalsCompletedNCT06994052Phase 4
- Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)CompletedNCT06987942Phase 4
- Efficacy and Safety of Fire Needle Therapy Combined With Cortex Phellodendri Compound Fluid Wet Compress for Acute Herpes Zoster: a Randomized Controlled Trial.CompletedNCT06985589Phase 4
- Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic NeuralgiaCompletedNCT06882525Not applicable
- Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and OlderActive, not recruitingNCT06851832Phase 1/2
- Rhomboid Intercostal and Subserratus Plane Block Versus Paravertebral Block for Thoracic Herpes ZosterCompletedNCT06751680Not applicable
- Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).CompletedNCT06654700Phase 3
- Obesity and Obesity-Related Factors and Risk of Herpes Zoster (Shingles) and Postherpetic NeuralgiaActive, not recruitingNCT06638177
- A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 YearsCompletedNCT06592456Phase 3
- A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster VaccineActive, not recruitingNCT06581575Phase 2
- Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and OverActive, not recruitingNCT06569823Phase 1/2
- Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and OlderActive, not recruitingNCT06447779Phase 3
- Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 YearsActive, not recruitingNCT06409494Phase 1
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsCompletedNCT06375512Phase 1
- Clinical Efficacy and Safety of Tender Point Infiltration (TPI) for Acute and Subacute Zoster Associated PainActive, not recruitingNCT06344403Not applicable
- A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 YearsActive, not recruitingNCT06335849Phase 1
- Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine CoverageCompletedNCT06334861
- Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the PhilippinesCompletedNCT06314724Phase 3
- Ultrasound-Guided Erectro Spinae Plane Block Versus Stellate Ganglion Block for Patients With Upper Limb Acute Herpes Zoster Pain.CompletedNCT06307444Not applicable
- Clinical and Economic Impact of Herpes Zoster in Cancer PatientsCompletedNCT06207487
- Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive, not recruitingNCT06070961
- A Study to Evaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 YearsCompletedNCT05991427Phase 1
- PREPARE-iVAC TrialCompletedNCT05924685Phase 4
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 4
- A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster VaccineCompletedNCT05871541Phase 1
- Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and AboveCompletedNCT05856084Phase 2
- A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of AgeActive, not recruitingNCT05839301Phase 3
- Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised ConditionsActive, not recruitingNCT05811754
- Non-inferiority Study of ZK-A03 in Treatment of Herpes Zoster Before and After the Alteration of the Active Ingredient ManufacturerStatus unknownNCT05806918Phase 3
- The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)CompletedNCT05769049Phase 1
- A Clinical Study of Freshly Manufactured 35kDa Hyaluronan Fragment in the Treatment of PainCompletedNCT05756595Not applicable
- A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster VaccineStatus unknownNCT05750017Phase 1
- Phase I Clinical Trial of a Candidate Herpes Zoster VaccineStatus unknownNCT05718037Phase 1
- A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsTerminatedNCT05703607Phase 1/2